Edmonton, Alberta, Canada, March 14, 2022 Pacylex Pharmaceuticals, an oncology company developing a first-in-class, oral drug for a new approach to cancer therapy, today announced the publication in the journal Current Oncology of data from the first patient. The paper entitl...